Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer

被引：0
|
作者：
Susan M. Farabaugh
Bonita T. Chan
Xiaojiang Cui
Robert K. Dearth
Adrian V. Lee
机构：
[1] University of Pittsburgh Cancer Institute,Women’s Cancer Research Center, Department of Pharmacology and Chemical Biology
[2] Magee Women’s Research Institute,Lester and Sue Smith Breast Center, Department of Molecular and Cellular Biology
[3] Baylor College of Medicine,undefined
来源：
Cell Communication and Signaling | / 14卷
关键词：
IRS; ErbB2; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Treatment of ErbB2 breast cancer by mitochondrial targeting
    Sophia Eldad
    Rachel Hertz
    Gilad Vainer
    Ann Saada
    Jacob Bar-Tana
    Cancer & Metabolism, 8
  • [22] Treatment of ErbB2 breast cancer by mitochondrial targeting
    Eldad, Sophia
    Hertz, Rachel
    Vainer, Gilad
    Saada, Ann
    Bar-Tana, Jacob
    CANCER & METABOLISM, 2020, 8 (01)
  • [23] Flotillins as regulators of ErbB2 levels in breast cancer
    S Pust
    T I Klokk
    N Musa
    M Jenstad
    B Risberg
    B Erikstein
    L Tcatchoff
    K Liestøl
    H E Danielsen
    B van Deurs
    K Sandvig
    Oncogene, 2013, 32 : 3443 - 3451
  • [24] A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer
    Naderi, Ali
    Hughes-Davies, Luke
    NEOPLASIA, 2008, 10 (06): : 542 - 548
  • [25] Prognosis in hormon receptor negative breast cancer patients according to ERBB2 status
    Dogan, L.
    Atalay, C.
    Yilmaz, K. B.
    Ozaslan, C.
    NEOPLASMA, 2008, 55 (06) : 544 - 548
  • [26] Identification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growth
    Yang, L.
    Li, Y.
    Zhang, Y.
    CELL DEATH & DISEASE, 2014, 5 : e1211 - e1211
  • [27] Identification of prolidase as a high affinity ligand of the ErbB2 receptor and its regulation of ErbB2 signaling and cell growth
    L Yang
    Y Li
    Y Zhang
    Cell Death & Disease, 2014, 5 : e1211 - e1211
  • [28] Heritable Variation of ERBB2 and Breast Cancer Risk
    Breyer, Joan P.
    Sanders, Melinda E.
    Airey, David C.
    Cai, Qiuyin
    Yaspan, Brian L.
    Schuyler, Peggy A.
    Dai, Qi
    Boulos, Fouad
    Olivares, Maria G.
    Bradley, Kevin M.
    Gao, Yu-Tang
    Page, David L.
    Dupont, William D.
    Zheng, Wei
    Smith, Jeffrey R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (04) : 1252 - 1258
  • [29] ERBB2 (HER2) Testing in Breast Cancer
    Hilal, Talal
    Romond, Edward H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (12): : 1280 - 1281
  • [30] A monoclonal antibody targeting ErbB2 domain III inhibits ErbB2 signaling and suppresses the growth of ErbB2-overexpressing breast tumors
    Y Meng
    L Zheng
    Y Yang
    H Wang
    J Dong
    C Wang
    Y Zhang
    X Yu
    L Wang
    T Xia
    D Zhang
    Y Guo
    B Li
    Oncogenesis, 2016, 5 : e211 - e211
12345